Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04053426
Other study ID # 38RC17.344
Secondary ID 2018-A00582-53
Status Completed
Phase
First received
Last updated
Start date July 19, 2018
Est. completion date March 31, 2021

Study information

Verified date May 2024
Source University Hospital, Grenoble
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Agitation in the intensive care unit is motor hyperactivity. It is frequent (b/w 30% to 70%) and has multiple causes: pain, medical reason, delirium, medication, etc. It can be a source of complication, for the patient, and equipment pullout. International recommendations state that the agitation should be taken care of with standardized protocols to improve patient care.


Description:

Data regarding patient characteristics and evaluation criterion will be collected automatically with the unit software (CCC, General Electrics) in specific file. Care and health teams enter the data systematically following the usual protocol. First Step : Follow-up and collection of data of patients included. Agitation evaluation with RASS scale, pain evaluation with BPS or NPRS. Second Step: Team training to delirium evaluation scale (CAM-ICU) and to the use of care algorithm. Third Step: Follow-up and collection of data of patients included. Use of care algorithm by doctors, nurses and back up training nurse to ensure daily information to health professionals of the care unit. Concomitant Step: Post discharge from care unit medical appointment to evaluate anxiety symptoms (HAD scale) and quality of life (SF-12)


Recruitment information / eligibility

Status Completed
Enrollment 138
Est. completion date March 31, 2021
Est. primary completion date March 31, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient presenting an agitation episode (RASS>1) - Intensive care unit hospitalization - Patient or next of kin if patient not able non opposed on participating to the study Exclusion Criteria: - Decision to limit life-sustaining therapy - Brain damage - Moribund patient - Patient participating to another trial excluding observational studies - The patient is pregnant or a lactating female - Patient under tutorship or curatorship and liberty deprived

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Implementation of agitation care algorithm
Following the agitation care algorithm care professional adapt their behavior regarding agitation

Locations

Country Name City State
France Grenoble University Hospital Grenoble

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Grenoble Fondation Apicil

Country where clinical trial is conducted

France, 

References & Publications (9)

Almeida TM, Azevedo LC, Nose PM, Freitas FG, Machado FR. Risk factors for agitation in critically ill patients. Rev Bras Ter Intensiva. 2016 Oct-Dec;28(4):413-419. doi: 10.5935/0103-507X.20160074. — View Citation

Barr J, Fraser GL, Puntillo K, Ely EW, Gelinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM, Coursin DB, Herr DL, Tung A, Robinson BR, Fontaine DK, Ramsay MA, Riker RR, Sessler CN, Pun B, Skrobik Y, Jaeschke R; American College of Critical Care Medicine. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013 Jan;41(1):263-306. doi: 10.1097/CCM.0b013e3182783b72. — View Citation

Chanques G, Jaber S, Barbotte E, Violet S, Sebbane M, Perrigault PF, Mann C, Lefrant JY, Eledjam JJ. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med. 2006 Jun;34(6):1691-9. doi: 10.1097/01.CCM.0000218416.62457.56. — View Citation

Ely EW, Stephens RK, Jackson JC, Thomason JW, Truman B, Gordon S, Dittus RS, Bernard GR. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: a survey of 912 healthcare professionals. Crit Care Med. 2004 Jan;32(1):106-12. doi: 10.1097/01.CCM.0000098033.94737.84. — View Citation

Ely EW, Truman B, Shintani A, Thomason JW, Wheeler AP, Gordon S, Francis J, Speroff T, Gautam S, Margolin R, Sessler CN, Dittus RS, Bernard GR. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA. 2003 Jun 11;289(22):2983-91. doi: 10.1001/jama.289.22.2983. — View Citation

Jaber S, Chanques G, Altairac C, Sebbane M, Vergne C, Perrigault PF, Eledjam JJ. A prospective study of agitation in a medical-surgical ICU: incidence, risk factors, and outcomes. Chest. 2005 Oct;128(4):2749-57. doi: 10.1378/chest.128.4.2749. — View Citation

Payen JF, Bosson JL, Chanques G, Mantz J, Labarere J; DOLOREA Investigators. Pain assessment is associated with decreased duration of mechanical ventilation in the intensive care unit: a post Hoc analysis of the DOLOREA study. Anesthesiology. 2009 Dec;111(6):1308-16. doi: 10.1097/ALN.0b013e3181c0d4f0. — View Citation

Payen JF, Chanques G, Mantz J, Hercule C, Auriant I, Leguillou JL, Binhas M, Genty C, Rolland C, Bosson JL. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology. 2007 Apr;106(4):687-95; quiz 891-2. doi: 10.1097/01.anes.0000264747.09017.da. — View Citation

Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med. 2014 Jan 30;370(5):444-54. doi: 10.1056/NEJMra1208705. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary RASS scale evaluation between phase "before" and phase "after" Comparison of the duration of agitation between phase "before" and phase "after" at the end of each phase, average of 1 year
See also
  Status Clinical Trial Phase
Terminated NCT03110900 - Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation Phase 4
Completed NCT05272501 - CAlming Touch for People With Agitation or Other Behavioural Symptoms of DEMentia - A Randomized Feasibility Trial N/A
Completed NCT06041646 - Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder Phase 4
Completed NCT06217146 - A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia. N/A
Recruiting NCT05543681 - IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's Phase 2
Recruiting NCT03513549 - Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder
Active, not recruiting NCT05658510 - Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III) Phase 3
Not yet recruiting NCT05612711 - Dronabinol for Agitation in Dementia Crossover Trial Phase 2
Recruiting NCT04957238 - Physical Restraints in Intensive Care Unit Patients N/A
Completed NCT03208452 - The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation Phase 4
Terminated NCT03899506 - Olanzapine Versus Midazolam for Agitation
Completed NCT03211897 - Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation N/A
Recruiting NCT05783505 - A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use N/A
Completed NCT03226522 - Addressing Dementia Via Agitation-Centered Evaluation Phase 2/Phase 3
Recruiting NCT03926520 - Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD) N/A
Recruiting NCT04075435 - Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia Early Phase 1
Completed NCT04276883 - Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder Phase 3
Completed NCT04797715 - Assessing Clinical Outcomes in Alzheimer's Disease Agitation Phase 3
Completed NCT04251910 - Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia Phase 1/Phase 2
Recruiting NCT05765162 - Safe Brain Initiative, Operationalizing Precision Anaesthesia